Clinical Trial - Water Therapy for Autosomal Dominant Polycystic Kidney Disease - Polycystic Kidney Disease

1 Answer

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
The study will involve 11 visits to the study site over 19 months. Participants will need to follow specific dietary and fluid recommendations. At each visit, patients will go through physical examinations and medical history assessments. Testing will include magnetic resonance imaging (MRI), blood and urine tests. Study participants will be compensated for their time. Interested patients can review detailed study procedures by contacting with the study team.
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 32 participants
Allocation: Non-Randomized
Intervention Model: Sequential Assignment
Intervention Model Description: Participants will have a period of usual fluid intake and a period of increased water intake over the course of the study.
Masking: Single (Outcomes Assessor)
Masking Description: The radiologist measuring kidney volumes will be masked to the study condition.
Primary Purpose: Treatment
Official Title: A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease
Actual Study Start Date : June 1, 2017
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : April 2019
Contact: Ines G Chicos 212-746-3541
Contact: Irina Barash, MD, MS 212-746-9077 Identifier: NCT03102632
For enrollment please visit